Nabulsi Azmi
- SEC CIK
- 0001791412
No open-market purchases or sales filed in the past year.
Current role at each company
- PHAT Phathom Pharmaceuticals, Inc.Chief Operating Officeras of Mar 3, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Nabulsi Azmi as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 23, 2025 (view filing) | Jan 21 | 2 days | Nabulsi AzmiChief Operating Officer | SSale | −7.89K | $6.59 | −$52.0K | −3.3%233.4K after | |
| Dec 20, 2024 (view filing) | Dec 19 | 1 day | Nabulsi AzmiChief Operating Officer | SSale | −1.12K | $8.00 | −$8.94K | −0.5%239.3K after | |
| Jul 17, 2024 (view filing) | Jul 15 | 2 days | Nabulsi AzmiChief Operating Officer | SSale | −10.9K | $11.72 | −$127.8K | −4.3%240.4K after | |
| Apr 11, 2023 (view filing) | Apr 11 | Same day | Nabulsi AzmiChief Operating Officer | PPurchase | +10.0K | $8.26 | +$82.6K | +11.2%99.6K after | |
| May 16, 2022 (view filing) | May 16 | Same day | Nabulsi AzmiChief Operating Officer | PPurchase | +20.0K | $8.16 | +$163.2K | +2.6%785.7K after |